How a Supreme Court fight over fish oil could raise your prescription drug costs

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...
pharmaphorum

Could a Novo error set up early GLP-1 generics in Canada?

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
The Great Outdoors on MSN

Dancing shadows: connecting with nature through chronic illness

Confined to the house with chronic illness, Louise Kenward discovered a community of artists continuing to connect with the natural worlds from their beds and homes. Here, she explores the rich and ...